Pharmaceutics (2021)
Update date:2022-09-26
Topics:
Trafalis, Dimitrios T.
Sagredou, Sofia
Dalezis, Panayiotis
Voura, Maria
Fountoulaki, Stella
Nikoleousakos, Nikolaos
Almpanakis, Konstantinos
Deligiorgi, Maria V.
Sarli, Vasiliki
The fusion of 1,2,4-triazole and 1,3,4-thiadiazole rings results in a class of heterocycles compounds with an extensive range of pharmacological properties. A series of 1,2,4-triazolo[3,4-b]-1,2,4-thiadiazoles was synthesized and tested for its enzyme inhibition potential and anticancer activity. The results show that 1,2,4-triazolo[3,4-b]-1,2,4-thiadiazoles display potent anticancer properties in vitro against a panel of cancer cells and in vivo efficacy in HT-29 human colon tumor xenograft in CB17 severe combined immunodeficient (SCID) mice. Preliminary mechanistic studies revealed that KA25 and KA39 exhibit time-and concentration-dependent inhibition of Akt Ser-473 phosphorylation. Molecular modeling experiments indicated that 1,2,4-triazolo[3,4-b]-1,2,4-thiadiazoles bind well to the ATP binding site in Akt1 and Akt2. The low acute toxicity combined with in vitro and in vivo anticancer activity render triazolo[3,4-b]thiadiazoles KA25, KA26, and KA39 promising cancer therapeutic agents.
View MoreHebei Fulong Import & Export Co., Ltd.
Contact:86-311-87795661
Address:15A19 Zhongyuan Building,368 Youyi North Street,Shijiazhuang 050070,China
Hubei Danao Pharmaceutical Co.,Ltd.
website:http://www.danaopharm.com
Contact:+86-719-5251167
Address:Fandan Road,Danjiangkou,Hubei
Shandong Xiangde Biotechnology Co., Ltd
Contact:+86 -15066639877
Address:Sanba street
Contact:+86-710-3516804
Address:Number 83,Panggong road,Xiangcheng District,Xiangyang ,Hubei
Contact:+86-570-4336358
Address:No.87 Building,Tianqian,Sidu Town
Doi:10.1016/S0040-4020(01)97658-6
(1981)Doi:10.1016/S0040-4039(00)92557-7
(1976)Doi:10.1021/jo00437a007
(1977)Doi:10.1071/CH03044
(2003)Doi:10.1002/anie.201906507
(2019)Doi:10.1021/jo00436a010
(1977)